Nobody prototypes a jet plane or car without running the empirical data
through a computer model. A clinical trial is also a prototype. Now,
pharmaceutical companies can simulate as many scenarios as necessary to
optimize success in the final design of their clinical trials.
Biosimulation technology from Immunetrics Inc. provides a bridge from
research and experiment to trial design. Immunetrics’
proprietary toolset provides predictive computer models based on
biological mechanisms. The inputs are patient data; the outputs are
predictions of clinical markers over time and clinically relevant
endpoints. Using this data, Immunetrics creates a simulation platform
for conducting virtual experiments that can help pharmaceutical
companies lock down the design of a human study that is optimized for
success.
Immunetrics is the only known mechanistic modeling company to provide
predictions of clinical trial outcomes that go far beyond pass or fail.
